Upgrade to SI Premium - Free Trial

TuHURA Biosciences files IND for TBS-2025 antibody in blood cancers

June 15, 2026 7:49 AM
TuHURA Biosciences Inc. (NASDAQ: HURA) filed an Investigational New Drug application with the U.S. Food and Drug Administration for its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA